CreditReports.dk
HomeScreen companies

15-Bio ApS Financials, key figures and credit report

CVR number: 39889277 Established 2018 Industry: 64 Financial service activities, except insurance and pension funding
Company contact details
Søndersøvej 15, 3500 Værløse rj@cytokipharma.com
Gross profit -6.9 kDKK FY 2025 +15.4% vs 2024
EBIT -6.9 kDKK FY 2025 +15.4% vs 2024
Net debt 26.4 kDKK FY 2025 +35.3% vs 2024
Quick ratio 0.0 FY 2025 +0 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit-5.75-5.17-5.00-8.13-6.88
EBIT-5.75-5.17-5.00-8.13-6.88
Other financial income1.59
Other financial expenses-1.41
Pre-tax profit-7.16-3.58-5.00-8.13-6.88
Net earnings-7.16-3.58-5.00-8.13-6.88

Assets (kDKK)

2021
2022
2023
2024
2025
Intangible assets total
Tangible assets total
Participating interests44.8044.8044.8044.8044.80
Investments total44.8044.8044.8044.8044.80
Long term receivables total
Inventories total
Short term receivables total
Cash and bank deposits1 780.380.030.030.080.20
Cash and cash equivalents1 780.380.030.030.080.20
Balance sheet total (assets)1 825.1844.8344.8344.8845.01

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital40.1040.1040.1040.1040.10
Retained earnings2.19-4.97-8.55-13.55-21.68
Profit of the financial year-7.16-3.58-5.00-8.13-6.88
Shareholders equity total35.1331.5526.5518.4211.55
Non-current liabilities total
Current owed to participating1 785.068.2813.2819.5826.58
Other non-interest bearing current liabilities5.005.005.006.886.88
Current liabilities total1 790.0613.2818.2826.4633.46
Balance sheet total (liabilities)1 825.1844.8344.8344.8845.01
Page generated